Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies. [electronic resource]
Producer: 20070313Description: 235-44 p. digitalISSN:- 1083-8791
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Busulfan -- administration & dosage
- Child
- Child, Preschool
- Female
- Hematopoietic Stem Cell Transplantation
- Histocompatibility Testing
- Humans
- Immunosuppressive Agents -- administration & dosage
- Infant
- Leukemia, Myeloid, Acute -- therapy
- Male
- Melphalan -- administration & dosage
- Methotrexate -- administration & dosage
- Middle Aged
- Myelodysplastic Syndromes -- therapy
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- therapy
- Prospective Studies
- Survival Analysis
- Tacrolimus -- administration & dosage
- Transplantation Conditioning -- methods
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.